![Mark Collins](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Collins
Directeur/Bestuurslid bij
LUNAI BIOWORKS INC.
Vermogen: 18 748 $ op 30-09-2026
Profiel
Dr. Mark A. Collins is an Independent Director at Lunai Bioworks, Inc. and a Chief Scientific Officer at Undaunted Bio, Inc. He is on the Board of Directors at Lunai Bioworks, Inc. Dr. Collins was previously employed as a Chief Technology Officer by Helomics Corp.
and a Vice President-Translational Service by icometrix NV.
He received his undergraduate degree from the University of Wolverhampton and a doctorate degree from the University of Surrey.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
LUNAI BIOWORKS, INC. 0,25% | 13-10-2026 | 12.754 ( 0,25% ) | 18 748 $ | 30-09-2026 |
Actieve functies van Mark Collins
| Bedrijven | Functie | Begin |
|---|---|---|
| LUNAI BIOWORKS INC. | Directeur/Bestuurslid | 14-10-2024 |
Eerdere bekende functies van Mark Collins
| Bedrijven | Functie | Einde |
|---|---|---|
Helomics Corp.
 Helomics Corp. Miscellaneous Commercial ServicesCommercial Services Provides cancer care development and treatment consulting services | Hoofd Techniek/Wetenschap/O&O | 01-01-2021 |
icometrix NV
 icometrix NV Packaged SoftwareTechnology Services Provides AI-powered brain imaging analysis for neurological disorders | Corporate Officer/Principal | 01-01-2021 |
Opleiding van Mark Collins
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
13
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Lunai Bioworks, Inc.
 Lunai Bioworks, Inc. BiotechnologyHealth Technology Operates as preclinical stage biotechnology company developing technologies and therapies for HIV, HBV and cancer | Health Technology |
Helomics Corp.
Helomics Corp. Miscellaneous Commercial ServicesCommercial Services Provides cancer care development and treatment consulting services | Commercial Services |
University of Wolverhampton
 University of Wolverhampton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Surrey
 University of Surrey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
icometrix NV
icometrix NV Packaged SoftwareTechnology Services Provides AI-powered brain imaging analysis for neurological disorders | Technology Services |
